Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company
New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) — Bowen Acquisition Corp (NASDAQ:BOWN) (“BOWN”), a special purpose acquisition company, announced the execution of an agreement and plan of merger (the “Merger Agreement”) with Shenzhen Qianzhi BioTechnology Co., Ltd (“Qianzhi BioTech”), a biotech company engaged in development, manufacturing and sales of ozonated health and wellness products in China.
Related news for (BOWN)
- Bowen Acquisition Corp Receives NASDAQ Notification of Non-Compliance with Listing Rules
- MoBot’s Stock Market Highlights – 03/19/25 12:00 PM
- MoBot alert highlights: NASDAQ: CSAI, NASDAQ: BOWN, NASDAQ: ADTX, NASDAQ: STI, NASDAQ: SUNE (03/19/25 11:00 AM)
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/19/25 10:00 AM